More about Ajanta Pharma Limited
Fundamentals for Ajanta Pharma Limited
Regulatory Filings for Ajanta Pharma Limited
IndiGo Implements Steep Fuel Surcharge as Iran Conflict Sends Jet Fuel Costs Soaring
The RBI's New Forex Fortress: Defensive Maneuvers in an Era of Oil Shocks
India's Fiscal Milestone: GST Collections Breach ₹2 Lakh Crore Mark for the First Time
AI Disruption Accelerates: Oracle Layoffs Raise Alarms for India’s Tech Workforce
Technicals for Ajanta Pharma Limited
Price Summary
On 2026-04-09, Ajanta Pharma Limited's stock began at 2710.4, peaked at 2764.6, declined to 2699.0, and ended the day 1.5% higher at 2751.0, with 76537 shares traded.During the 52-week span, the stock hit a high of 3119.5 and a low of 0.0.
As per recommendations from 12 analysts, AJANTPHARM's future price is expected to span between 2605.0 and 3742.0, with a mean price around 3207.5833.
Technicals
Support and Resistance: The price currently sits at 2751.0, finding support at 2734.5 and resistance at 2949.2. These levels define a range for Ajanta Pharma Limited where the price may move, with 2734.5 offering a base and 2949.2 limiting upward momentum.Aroon: The AROON is showing a neutral reading, with no clear direction indicated for upward or downward movement. This neutral position suggests a possible period of consolidation.
Bol. Bands: The BOLL BANDS is showing a neutral reading, with no clear direction indicated for upward or downward movement. This neutral position suggests a possible period of consolidation.
Parabolic SAR: The PSAR continues to signal a bearish outlook, establishing a resistance level that could act as a ceiling for upward trends. This resistance suggests that the market may struggle to overcome bearish forces, keeping prices under pressure.
Stochastic: The K-line has crossed above the D-line on the stochastic indicator, while remaining below 20, indicating a possible bullish move. This pattern is often viewed as a signal that the market might start to rise from a low point, potentially leading to gains. Investors might see this as a favorable entry opportunity.
Tripple Moving Agerage: The Tripple MOVING AVG is showing a neutral stance, not indicating a clear upward or downward trend for Ajanta Pharma Limited. This suggests a period of market balance, where neither side is showing dominance.
Analyzing the technical indicators of a company, such as stock price and trading volume, requires first understanding its fundamentals. These fundamentals include profitability, growth potential, and market position. Furthermore, knowing the broader industry trends and competitive landscape provides critical context. When both the company's internal data and the external environment are considered, it allows for more meaningful conclusions about the company's technical performance and future trajectory.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
U.S. Labor Market in 2026: JOLTS and Consumer Confidence Reveal Why Hiring Cooled Without Unemployment Spike
Lending Unleashed: Assessing the Impact of the Federal Reserve’s Capital Rollback
Calendar Collision: How Mahavir Jayanti's Overlap With Fiscal Year-End Reshapes India's Tax-Loss Harvesting Landscape